Literature DB >> 35356641

When and How to Adjust Non-Pharmacological Interventions Concurrent with Booster Vaccinations Against COVID-19 - Guangdong, China, 2022.

Guanhao He1, Fangfang Zeng2,3, Jianpeng Xiao4, Jianguo Zhao4, Tao Liu2, Jianxiong Hu4, Sicong Zhang5, Ziqiang Lin6, Huaiping Zhu7, Dan Liu2, Min Kang1, Haojie Zhong1, Yan Li1, Limei Sun1, Yuwei Yang1, Zhixing Li2, Zuhua Rong4, Weilin Zeng4, Xing Li4, Zhihua Zhu4, Xiaofeng Liang3,8, Wenjun Ma2,3.   

Abstract

Introduction: With the large-scale roll-out of the coronavirus disease 2019 (COVID-19) booster vaccination effort (a vaccine dose given 6 months after completing primary vaccination) in China, we explore when and how China could lift non-pharmacological interventions (NPIs) against COVID-19 in 2022.
Methods: Using a modified susceptible-infectious-recovered (SIR) mathematical model, we projected the COVID-19 epidemic situation and required medical resources in Guangdong Province, China.
Results: If the number of people entering from overseas recovers to 20% of the number in 2019, the epidemic in 2022 could be controlled at a low level by a containment (215 local cases) or suppression strategy (1,397 local cases). A mitigation strategy would lead to 21,722 local cases. A coexistence strategy would lead to a large epidemic with 6,850,083 local cases that would overwhelm Guangdong's medical system. With 50% or 100% recovery of the 2019 level of travelers from overseas, the epidemic could also be controlled with containment or suppression, but enormous resources, including more hotel rooms for border quarantine, will be required. However, coexistence would lead to an uncontrollable epidemic with 12,922,032 local cases. Discussion: With booster vaccinations, the number of travelers from overseas could increase slightly in 2022, but a suppression strategy would need to be maintained to ensure a controllable epidemic. Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022.

Entities:  

Keywords:  COVID-19; Prevention strategy adjustment; booster vaccination; non-pharmacological interventions

Year:  2022        PMID: 35356641      PMCID: PMC8930405          DOI: 10.46234/ccdcw2022.048

Source DB:  PubMed          Journal:  China CDC Wkly        ISSN: 2096-7071


  10 in total

1.  Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.

Authors:  An Pan; Li Liu; Chaolong Wang; Huan Guo; Xingjie Hao; Qi Wang; Jiao Huang; Na He; Hongjie Yu; Xihong Lin; Sheng Wei; Tangchun Wu
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

2.  Global socio-economic losses and environmental gains from the Coronavirus pandemic.

Authors:  Manfred Lenzen; Mengyu Li; Arunima Malik; Francesco Pomponi; Ya-Yen Sun; Thomas Wiedmann; Futu Faturay; Jacob Fry; Blanca Gallego; Arne Geschke; Jorge Gómez-Paredes; Keiichiro Kanemoto; Steven Kenway; Keisuke Nansai; Mikhail Prokopenko; Takako Wakiyama; Yafei Wang; Moslem Yousefzadeh
Journal:  PLoS One       Date:  2020-07-09       Impact factor: 3.240

3.  SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.

Authors:  Angela Wahl; Lisa E Gralinski; Claire E Johnson; Wenbo Yao; Martina Kovarova; Kenneth H Dinnon; Hongwei Liu; Victoria J Madden; Halina M Krzystek; Chandrav De; Kristen K White; Kendra Gully; Alexandra Schäfer; Tanzila Zaman; Sarah R Leist; Paul O Grant; Gregory R Bluemling; Alexander A Kolykhalov; Michael G Natchus; Frederic B Askin; George Painter; Edward P Browne; Corbin D Jones; Raymond J Pickles; Ralph S Baric; J Victor Garcia
Journal:  Nature       Date:  2021-02-09       Impact factor: 49.962

4.  Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.

Authors:  Allison L Naleway; Holly C Groom; Phil M Crawford; S Bianca Salas; Michelle L Henninger; Judy L Donald; Ning Smith; Mark G Thompson; Lenee H Blanton; Catherine H Bozio; Eduardo Azziz-Baumgartner
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-11-19       Impact factor: 17.586

Review 5.  Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.

Authors:  Caifang Zheng; Weihao Shao; Xiaorui Chen; Bowen Zhang; Gaili Wang; Weidong Zhang
Journal:  Int J Infect Dis       Date:  2021-11-17       Impact factor: 3.623

6.  Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.

Authors:  Noam Barda; Noa Dagan; Cyrille Cohen; Miguel A Hernán; Marc Lipsitch; Isaac S Kohane; Ben Y Reis; Ran D Balicer
Journal:  Lancet       Date:  2021-10-29       Impact factor: 79.321

7.  Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.

Authors:  Stella Talic; Shivangi Shah; Holly Wild; Danijela Gasevic; Ashika Maharaj; Zanfina Ademi; Xue Li; Wei Xu; Ines Mesa-Eguiagaray; Jasmin Rostron; Evropi Theodoratou; Xiaomeng Zhang; Ashmika Motee; Danny Liew; Dragan Ilic
Journal:  BMJ       Date:  2021-11-17

8.  Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.

Authors:  Finlay Campbell; Brett Archer; Henry Laurenson-Schafer; Yuka Jinnai; Franck Konings; Neale Batra; Boris Pavlin; Katelijn Vandemaele; Maria D Van Kerkhove; Thibaut Jombart; Oliver Morgan; Olivier le Polain de Waroux
Journal:  Euro Surveill       Date:  2021-06

9.  Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.

Authors:  Alejandro Jara; Eduardo A Undurraga; Cecilia González; Fabio Paredes; Tomás Fontecilla; Gonzalo Jara; Alejandra Pizarro; Johanna Acevedo; Katherine Leo; Francisco Leon; Carlos Sans; Paulina Leighton; Pamela Suárez; Heriberto García-Escorza; Rafael Araos
Journal:  N Engl J Med       Date:  2021-07-07       Impact factor: 91.245

10.  Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021.

Authors:  Juan Yang; Valentina Marziano; Xiaowei Deng; Giorgio Guzzetta; Juanjuan Zhang; Filippo Trentini; Jun Cai; Piero Poletti; Wen Zheng; Wei Wang; Qianhui Wu; Zeyao Zhao; Kaige Dong; Guangjie Zhong; Cécile Viboud; Stefano Merler; Marco Ajelli; Hongjie Yu
Journal:  Nat Hum Behav       Date:  2021-06-22
  10 in total
  1 in total

1.  Statistical inference using GLEaM model with spatial heterogeneity and correlation between regions.

Authors:  Yixuan Tan; Yuan Zhang; Xiuyuan Cheng; Xiao-Hua Zhou
Journal:  Sci Rep       Date:  2022-10-05       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.